Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Last 1/4 earning should have said...

Last 1/4 earning should have said...

posted on Feb 19, 2010 06:34PM

should have said ... PTSC excluding one time charges profits of .01 cents...(3 million) ...

so I am surprised we have not seen more price action.. I am sure we will see a profitable 1/4 1st one in a while...

oh yeah where is our ARS settlements...

cash grew by 3 million.. so lets buys back some stock!!! now

Share
New Message
Please login to post a reply